In anticipation of the vote this coming Tuesday on Oregon Measure 109, attorney Graham Pechenik and I discussed whether patent law gives the right to “own” a psychedelic molecule, what Compass Pathways’ patent means, and how patent law might interact with a state law legalizing manufacture and supervised therapeutic use of psychedelic substances.

(To skip over the discussion of how patents work generally and listen to discussion of the Oregon initiative, go to 18:11.)